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are adjacent to the insertions of the ACL. Potentially, the cartilage may
swell or hypertrophy in these regions due to an involvement of the ACL
during injury. Our results suggest that the pattern of cartilage loss may
differ slightly between post traumatic OA and primary OA knees.
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Purpose: To determine whether 3D shape of the femur and tibia are
predictive of the incidence of osteoarthritis, and the usefulness of 3D shape
as a marker of occurrence.
Methods: Radiographs were drawn from 1000 subjects of the incidence
cohort of the publicly released OAI dataset. Paired images at baseline, 12, 24
and 36 months were read by an experienced reader to determine possible
incident x-ray OA cases (deﬁned as KL≥2) in knees without OA at baseline
(KL≤2)) over the follow-up. A second experienced reader independently
read paired images of these possible cases mixed with controls. Incident OA
cases were deﬁned only when both readers agreed independently. Cases
with any lateral OA were excluded. 2 controls were selected per case,
matched on KL grade at baseline.
Baseline DESS-we images from the OAI dataset were used to identify
vectors which were best able to discriminate subjects with OA from those
who did not have OA. A statistical model of the femur and tibia bone
surfaces, built from an unrelated dataset, was automatically ﬁtted to each
image of a training dataset of subjects from the OAI control group and the
O.B.1 group. This resulted in ﬁtting a standardized grid of points to the
femur and tibia within each image. We used linear discriminant analysis
to identify the vectors which best separated the groups; separate vectors
were identiﬁed for the femur, the tibia and the combined bones.
For the current study, the bone model was ﬁtted to each of the case and
control images at baseline and at each annual follow-up. The resultant
shape was projected onto the vectors described above. For each image, this
produces a single value of the distance along the vector, which is scaled so
that the mean non-OA shape is represented as -1, the mean OA shape as +1.
Results: Comparing baseline images when no OA was present in either
46 cases or 92 controls, a t-test of the difference between the population
means for the value of the vector was not signiﬁcant using the tibia
vector. Using the femoral vector a small but signiﬁcant difference was
found (difference between means = 0.24, p = 0.01), but this is too small
a difference to predict later incidence of OA. With follow-up as the cases
developed radiographic OA, all of the vectors (femur, tibia and combined)
showed separation of the case and control groups, a separation which
increased with time (see Figure 1 for the results for the combined vector).
The results for the combined vector are shown in Figure 1. Table 1 shows
the amount of change at each time point using the combined vector. The
high SRM value at years 2 and 3 with this cohort suggest that this is a
highly sensitive measure of disease occurrence and possibly progression.
Figure 1. Figure shows change in the value of the combined vector from baseline for the
femur and tibia in case and control groups, with 95% conﬁdence limits. n for case group
was 46, 44, 41 and 36 at 0, 12, 24 and 36 months. Control group n was 92, 89, 77 and 69.
Conclusions: There is a small but signiﬁcant difference between the groups
at baseline, which does not predict the likelihood of OA incidence. However,
Table 1. Differences in value of the combined vector between cases and controls by length
of follow-up
12 months 24 months 36 months
Mean change since baseline 0.120 0.359 0.470
95% Conﬁdence limits (0.04, 0.2) (0.26, 0.46) (0.34, 0.6)
p-value 0.00535 8.77E-09 1.13E-08
SRM 0.442 1.130 1.235
as OA develops, the vectors for femur, tibia and combined bone change,
discriminating robustly between developing OA and non-OA. Bone shape
does not appear to be a predictor of disease onset, but changes either
before or concurrent with disease development. The sensitivity of the
change in 3D shape, as judged by the SRM value, suggests that 3D shape
could be used as a biomarker to assess OA progression in clinical trials.
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It is increasingly appreciated that synovitis may be observed even in
early OA. Chronic inﬂammation and angiogenesis are closely integrated
processes. Arthroscopic studies suggest that localized proliferative and
inﬂammatory changes of the synovium occur in up to 50% of OA patients,
in MRI studies even up to 73%. Power Doppler ultrasound (PDU) is recog-
nized method in assessment of synovial vascularity but still inadequate in
quantiﬁcation of slow ﬂow in microvessels formed in angiogenesis.
Purpose: To investigate contrast-enhanced ultrasound (CEUS) potential
in detection and quantiﬁcation of synovial vascularity of early knee os-
teoarthritis (KOA) patients in comparison of knee symptoms, PDU and
synovial biopsy.
Methods: CEUS was performed to 24 patients (M/F 16/8) who were on
waiting list for arthroscopy and agreed to pass an additional test. Patients
were in age 34-60 (mean 48 yrs) and had BMI 21.5-36.5 (mean 28.1). Knee
symptoms had lasted in average 1.5 years. Radiographic OA distributed as
grade 0 in 31%, grade1 in 52% and grade 2+ in 17% of cases.
Function limitations and knee pain were evaluated using KOOS index.
Synovial vascularity was assessed by and CEUS examinations with Sequoia
512 (Siemens) US equipment using multifrequency linear 14 MHz trans-
ducer. PDU signal was graded on a scale of 0-3 (0=absent to 3=marked). All
patients underwent CEUS with SonoVue® (Bracco). For CEUS a commercial
vascular recognition imaging and quantitative assessment software were
used. For description of synovial vascularity three contrast quantiﬁcation
characteristics, arrival time (AT), time to peak (TTP) and peak intensity (PI),
were used.
Arthroscopy was performed via usual anterolateral and anteromedial
femorotibial portals 2-3 weeks after KOOS and US evaluation. Synovial
membrane biopsy specimens were taken under direct visualisation from
areas of macroscopically apparent synovial changes. In 18 cases immuno-
chemical staining with factor VIII was used to detect synovial new blood
vessel formation. Non-parametric statistics were used.
Results: The results distributed according to AT: without clear contrast
arrival peak (group I, n=10), with early perfusion (group II, AT less than 30
sec, n=7) and group III with later perfusion (AT longer than 30 sec, n=7).
KOOS subscales Symptoms (p 0.02), limitations in ADL and Sport/Recreat
(p 0.03) were signiﬁcantly more expressed in patients from group II and
III compared to group I, but no difference was observed between groups II
and III.
Number of synovial blood vessels in PF turned to be higher in groups II and
III (medians 52 and 50) in comparison of group I (median 35, p= 0.06 and
0.01, respectively). Signiﬁcant correlation was observed between the AT
values and number of synovial blood vessels (rho =0.624, n=18, p=0.006).
At the same time no correlation was found between the vessels’ number
and PDU results. Discrepant results of CEUS and PDU results were observed
primarily in group III (Fisher exact p=0.021), when only no ﬂow or minimal
ﬂow was seen by PDU.
